AC
ANGO icon

Armistice Capital’s AngioDynamics ANGO Stock Holding History

Armistice Capital’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6M Buy
2,198,000
+329,000
+18% +$3.74M 0.35% 44
2026
Q1 		$21.3M Buy
1,869,000
+169,000
+10% +$1.83M 0.38% 54
2025
Q4 		$21.8M Buy
1,700,000
+64,000
+4% +$790K 0.26% 63
2025
Q3 		$18.3M Buy
1,636,000
+108,185
+7% +$1.04M 0.27% 59
2025
Q2 		$15.2M Sell
1,527,815
-566,185
-27% -$5.54M 0.26% 52
2025
Q1 		$19.7M Buy
2,094,000
+1,222,000
+140% +$12.8M 0.29% 65
2024
Q4 		$7.99M Sell
872,000
-90,000
-9% -$662K 0.11% 103
2024
Q3 		$7.48M Buy
962,000
+126,000
+15% +$910K 0.12% 105
2024
Q2 		$5.06M Sell
836,000
-36,000
-4% -$222K 0.06% 115
2024
Q1 		$5.12M Buy
872,000
+72,000
+9% +$428K 0.07% 124
2023
Q4 		$6.27M Buy
+800,000
New +$5.55M 0.09% 114

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Armistice Capital's ANGO Position: Q2 2026 in Review

Armistice Capital increased its AngioDynamics (ANGO) stake by 18% in Q2 2026, buying an estimated $3.74M and bringing the position to 2,198,000 shares worth $28.6M. The position accounts for 0.35% of the portfolio, ranked #44.

Armistice Capital first reported a position in ANGO in Q4 2023 and has held it in 11 quarters since. 162 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Armistice Capital held 2,198,000 shares of AngioDynamics worth $28.6M as of Q2 2026.
  • Armistice Capital bought 329,000 AngioDynamics shares in Q2 2026, an estimated $3.74M.
  • AngioDynamics made up 0.35% of Armistice Capital's portfolio in Q2 2026, its #44 holding.
  • Armistice Capital first reported a position in AngioDynamics in Q4 2023 and has held it in 11 quarters since.
  • 162 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.